BioSpace News Archive

Job Trends

CherryCircle Software Unveils Enhanced QbDVision® Platform to Transform Pharma Product Life Cycle - June 18, 2019

Flagship platform for pharmaceutical process development and manufacturing expanded to streamline compliant workflows with integrated functionality

June 18, 2019
·
4 min read
Business

VALO THERAPEUTICS APPOINTS MICHAEL STEIN AS CHIEF EXECUTIVE OFFICER

Seasoned Healthcare Entrepreneur strengthens Management Team

June 18, 2019
·
3 min read
Pharm Country

Menarini Silicon Biosystems Introduces Use of DEPArray System for Challenging Flow Cytometry Applications at CYTO Congress

Digital cell sorting technology enables greater precision and accuracy for samples with rare targets and low cell counts

June 18, 2019
·
4 min read
FDA

Kowa Pharmaceuticals America, Inc. Receives Pediatric Indication and Six-Month Pediatric Exclusivity for LIVALO® (pitavastatin)

Kowa Pharmaceuticals America, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the cholesterol-lowering drug LIVALO® (pitavastatin) for pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (Apo B).

June 18, 2019
·
8 min read
Business

Medicine Man Technologies, Inc. Announces Appointments of New Chief Strategy Officer and VP of Integration

Todd Williams brings 24+ years of consulting, asset valuation and M&A strategy experience to his role as Chief Strategy Officer

June 18, 2019
·
4 min read
Drug Development

Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma

Durable Responses Observed in DLBCL and Indolent Lymphoma; Median Duration of Response Not Yet Reached

June 18, 2019
·
12 min read
Policy

ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing

Marks Second Product Approval from Health Canada This Year

June 18, 2019
·
3 min read
Drug Development

Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma

Disease control rate of up to 83% achieved; evidence of improved survival for patients

June 18, 2019
·
8 min read
Drug Development

BioMarin Announces New England Journal of Medicine Publishes Vosoritide Phase 2 Study Showing Sustained Annualized Growth Up to 42 Months in Children with Achondroplasia

Company Announces Enrollment Met for 2-5 Year-Old Cohort in Separate Phase 2 Study in Infants and Young Children

June 18, 2019
·
10 min read
Business

Group K Diagnostics Expands Research Team, Updates Lab and Manufacturing Facilities

Enhancements will triple manufacturing output capacity, improve production speed six-fold

June 18, 2019
·
2 min read